Results 121 to 130 of about 30,112 (235)
A Primary Retroperitoneal Mucinous Tumor
A twenty-five-year-old female presented with a large retroperitoneal mass. Workup included history and physical exam, imaging, biopsy, colonoscopy, and gynecologic exam.
Alicia A. Heelan Gladden +3 more
doaj +1 more source
Changes in ovarian cancer survival during the 20 years before the era of targeted therapy
Background The survival of patients with ovarian cancer has improved because of surgery and chemotherapy. This study aimed to estimate the changes in survival rates among Korean women with ovarian cancer prior to the introduction of targeted therapy for ...
Jung-Yun Lee +8 more
doaj +1 more source
Tubular Krukenberg Tumor with an Occult Primary [PDF]
Tubular Krukenberg tumor with an occult primary can cause problems in histopathologic diagnosis, by mimicking primary ovarian tumors. We present one such occurrence in a 32year old female who underwent surgery for bilateral malignant ovarian tumor. Gross
Kaur, N, Kaushal, V, Mardi, K
core +1 more source
Protein glycosylation in lung cancer from a mass spectrometry perspective
ABSTRACT Lung cancer is a severe disease for which better diagnostic and therapeutic approaches are urgently needed. Increasing evidence implies that aberrant protein glycosylation plays a crucial role in the pathogenesis and progression of lung cancer.
Mirjam Balbisi +2 more
wiley +1 more source
Metastatic Ovarian Mucinous Carcinoma Presenting as Ileocecal Adenocarcinoma: A Case Report. [PDF]
Glombicki SE +5 more
europepmc +1 more source
Editor's Note: Targeting Src in Mucinous Ovarian Carcinoma [PDF]
Koji, Matsuo +23 more
openaire +2 more sources
ABSTRACT Epstein‐Barr virus (EBV) is a ubiquitous herpesvirus and a causal factor for Burkitt Lymphoma (BL), Hodgkin Lymphoma (HL), gastric carcinoma (GC) and nasopharyngeal carcinoma (NPC). Whether EBV contributes to a wider spectrum of cancers remains uncertain.
Marisa D. Muckian +4 more
wiley +1 more source
Bilateral ovarian mucinous carcinoma (stage III) with omental involvement and incidental hydronephrosis: A rare case report. [PDF]
Poudel D +5 more
europepmc +1 more source
Recent Therapies and Biomarkers in Mucinous Ovarian Carcinoma
Mucinous ovarian carcinoma (MOC) represents a rare and biologically distinct subtype of ovarian cancer, characterized by poor response to standard platinum-based chemotherapy and a unique molecular profile, including frequent KRAS mutations and HER2 amplifications. Recent advancements in targeted therapy, such as HER2 inhibitors and KRASG12C inhibitors,
Grzegorz Przywara +7 more
openaire +3 more sources

